Cargando…

Helicobacter pylori and Pathogenesis

Detalles Bibliográficos
Autores principales:	Tomoda, Akio, Kamiya, Shigeru, Suzuki, Hidekazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407402/ https://www.ncbi.nlm.nih.gov/pubmed/25949992 http://dx.doi.org/10.1155/2015/304768

Ejemplares similares

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis
por: Suzuki, Hidekazu, et al.
Publicado: (2009)

Biofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance
por: Yonezawa, Hideo, et al.
Publicado: (2015)

Metalloregulation of Helicobacter pylori physiology and pathogenesis
por: Haley, Kathryn P., et al.
Publicado: (2015)

Role of Flagella in the Pathogenesis of Helicobacter pylori
por: Gu, Haiying
Publicado: (2017)

Review: Pathogenesis of Helicobacter pylori infection
por: Chmiela, Magdalena, et al.
Publicado: (2019)

Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing
por: Nishizawa, Toshihiro, et al.
Publicado: (2014)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Update on quinolone-containing rescue therapies for Helicobacter pylori infection
por: Mori, Hideki, et al.
Publicado: (2020)

Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan
por: Suzuki, Sho, et al.
Publicado: (2023)

Helicobacter pylori: present status and future prospects in Japan
por: Suzuki, Hidekazu, et al.
Publicado: (2007)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

Regulation of p53 by Helicobacter pylori
por: Zaika, Alexander, et al.
Publicado: (2012)

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication
por: Nishizawa, Toshihiro, et al.
Publicado: (2009)

Role of γ-glutamyltranspeptidase in the pathogenesis of Helicobacter suis and Helicobacter pylori infections
por: Zhang, Guangzhi, et al.
Publicado: (2015)

Special issue: Helicobacter pylori
por: Peek, Richard M
Publicado: (2013)

Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2015)

What Is the Difference Between Helicobacter pylori-Associated Dyspepsia and Functional Dyspepsia?
por: Suzuki, Hidekazu, et al.
Publicado: (2011)

The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood
por: Kato, Seiichi, et al.
Publicado: (2020)

Self-Medication With Analgesics and Helicobacter pylori Infection
por: Metanat, Maliheh
Publicado: (2015)

Helicobacter pylori infection and osteoporosis in elderly patients
por: Heidari, Behzad
Publicado: (2015)

Helicobacter pylori Infection and Upper Gastrointestinal Disorders
por: Kate, Vikram, et al.
Publicado: (2013)

Helicobacter pylori: Infection and New Perspective for the Treatment
por: Fasciana, Teresa, et al.
Publicado: (2019)

Strategies for Helicobacter pylori eradication in the year 2020
por: Pellicano, Rinaldo, et al.
Publicado: (2020)

Inflammation at the crossroads of Helicobacter pylori and COVID-19
por: Gonzalez, Ileana, et al.
Publicado: (2021)

Role of Tegoprazan in Helicobacter pylori Eradication Therapy
por: Lee, Jin
Publicado: (2022)

Helicobacter pylori Outer Membrane Protein-Related Pathogenesis
por: Matsuo, Yuichi, et al.
Publicado: (2017)

Pathogenesis and clinical management of Helicobacter pylori gastric infection
por: de Brito, Breno Bittencourt, et al.
Publicado: (2019)

Editorial: The pathogenesis and treatment of Helicobacter pylori-induced diseases
por: Xu, Yifei, et al.
Publicado: (2023)

Impact of Helicobacter pylori Biofilm Formation on Clarithromycin Susceptibility and Generation of Resistance Mutations
por: Yonezawa, Hideo, et al.
Publicado: (2013)

Helicobacter pylori and gastric cancer: time for mega-trials?
por: Danesh, J
Publicado: (1999)

23 years of the discovery of Helicobacter pylori: Is the debate over?
por: Ahmed, Niyaz
Publicado: (2005)

Glimpse of the Epidemiological Research on Helicobacter Pylori in Saudi Arabia
por: BinSaeed, Abdulaziz A.
Publicado: (2009)

Helicobacter pylori: Have potential benefits been overlooked?
por: Schubert, Jonathon P, et al.
Publicado: (2022)

Refractory Helicobacter pylori treatment in resource‐limited settings
por: Mahadeva, Sanjiv
Publicado: (2023)

Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

The Role of Helicobacter pylori and NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer
por: Cekin, Ayhan Hilmi, et al.
Publicado: (2012)

The Role of microRNAs in Helicobacter pylori Pathogenesis and Gastric Carcinogenesis
por: Noto, Jennifer M., et al.
Publicado: (2012)

The Role of Helicobacter pylori Outer Membrane Proteins in Adherence and Pathogenesis
por: Oleastro, Mónica, et al.
Publicado: (2013)

Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
por: Okushin, Kazuya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ccsnq75o41ga10h3e2973ucrm